Rituxan (rituximab) - Roche
Late-Onset Neutropenia and Hypogammaglobulinemia After Dose-Adjusted R-EPOCH in Unfavorable Diffuse Large B-Cell Lymphoma. (PubMed, Life (Basel)) - Sep 27, 2026 - "After DA-R-EPOCH, LON is a delayed and largely transient event separate from end-of-treatment neutropenia, whereas hypogammaglobulinemia is more persistent and clinically relevant for respiratory infections." 
Journal • B Cell Lymphoma • B Cell Non-Hodgkin Lymphoma • Diffuse Large B Cell Lymphoma • Gastroenterology • Gastrointestinal Disorder • Hematological Disorders • Hematological Malignancies • Infectious Disease • Lymphoma • Neutropenia • Non-Hodgkin's Lymphoma • Oncology • Respiratory Diseases • Sarcopenia • Transplantation
http://www.ncbi.nlm.nih.gov/pubmed/42795255
 
Marija Ivi? ?ikara; Rafaela Filipan
 
Sep 27, 2026
 
Prev Next